evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract
19758,GENE_BACKGROUND,,"CRKL encodes an adaptor protein (CRK-Like) with SH2 and SH3 domains that facilitates signal transduction from kinases to downstream targets (PMID:10648385). It is a target of the BCR-ABL translocation kinase and enhances transformation in CML (chronic myelogenous leukemia) (PMID:20807813). CRKL can activate the Ras, Rac, and Jun kinase signaling pathways (PMID:12393632, 11443118, 10514505). Pathway activation mediates diverse cellular processes involved in cancer including cell proliferation, EMT (epithelial to mesenchymal transition), and invasion (PMID:26044596, 25661331,25318601). CRKL amplification has been identified in lung carcinomas and gastric cancer (PMID:22591714, 22586683). Amplification can be a means of acquired resistance to targeted therapy in EGFR lung cancer (PMID:22586683).",,2017-03-01,,1399,CRKL,"CRK like proto-oncogene, adaptor protein",True,ENST00000354336,NM_005207.3,False,11443118,CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling.,The Journal of biological chemistry,2018-08-31T20:01:00,276,35,33282-90,Arai A et al,,,0001-08-31,,26044596,CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.,Cytokine,2017-12-01T20:15:00,76,2,163-169,Han G et al,doi: 10.1016/j.cyto.2015.05.009,,0001-12-01,,25661331,"CRKL overexpression suppresses in vitro proliferation, invasion and migration of murine hepatocarcinoma Hca-P cells.",Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie,2018-02-01T20:15:00,69,,2001-11-07,Lin Q et al,doi: 10.1016/j.biopha.2014.10.025,,0001-02-01,,22586683,Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers.,Cancer discovery,2017-12-01T20:11:00,True,7,608-25,Cheung HW et al,doi: 10.1158/2159-8290.CD-11-0046,,0001-12-01,,10514505,CrkL mediates Ras-dependent activation of the Raf/ERK pathway through the guanine nucleotide exchange factor C3G in hematopoietic cells stimulated with erythropoietin or interleukin-3.,The Journal of biological chemistry,0001-10-15,274,42,30154-62,Nosaka Y et al,,,0001-10-15,,10648385,Adaptor proteins CRK and CRKL associate with the serine/threonine protein kinase GCKR promoting GCKR and SAPK activation.,Blood,2018-02-01T20:00:00,95,3,776-82,Shi CS et al,,,0001-02-01,,20807813,A specific need for CRKL in p210BCR-ABL-induced transformation of mouse hematopoietic progenitors.,Cancer research,2018-09-15T20:10:00,70,18,7325-35,Seo JH et al,doi: 10.1158/0008-5472.CAN-10-0607,,0001-09-15,,12393632,DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines.,Blood,2017-12-01T20:02:00,100,12,3968-74,Nishihara H et al,,,0001-12-01,,25318601,CRKL protein overexpression enhances cell proliferation and invasion in pancreatic cancer.,Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,2018-02-01T20:15:00,36,2,1015-22,Fu L et al,doi: 10.1007/s13277-014-2706-2,,0001-02-01,,22591714,"The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer.",Journal of translational medicine,2018-07-03T20:12:00,10,,97,Natsume H et al,doi: 10.1186/1479-5876-10-97,,0001-07-03,
19757,GENE_SUMMARY,,CRKL encodes an adaptor protein that facilitates signal transduction from multiple different kinases to downstream targets. CRK is an oncogene that can be overexpressed and amplified in solid tumors.,,2017-03-01,,1399,CRKL,"CRK like proto-oncogene, adaptor protein",True,ENST00000354336,NM_005207.3,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
